CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

315

HTML

2308

Figures (1-2)

140

Tables (1-1)

131

Sum=2894

Feb 28, 2005 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 28, 2005; 11(8): 1220-1224
Published online Feb 28, 2005. doi: 10.3748/wjg.v11.i8.1220

Table 1 NK cell activity of hepatoma-bearing mice receiving different treatments.

^aP<0.05 vs the control group.

Citation: Wang XS, Sheng Z, Ruan YB, Guang Y, Yang ML. CpG oligodeoxynucleotides inhibit tumor growth and reverse the immunosuppression caused by the therapy with 5-fluorouracil in murine hepatoma. World J Gastroenterol 2005; 11(8): 1220-1224
URL: https://www.wjgnet.com/1007-9327/full/v11/i8/1220.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i8.1220